SOLV · 10-Q · 2026Q2 · Full report

Liquidity and Cash Position

Solventum Corp · 2026-08-05 · Importance 44 · Surprise 46 · No source text

Cash and cash equivalents declined to $403 million at June 30, 2026 from $878 million at December 31, 2025. Foreign subsidiaries held approximately $291 million of June 30 cash, while the United States held approximately $112 million. Solventum had no commercial paper outstanding at June 30, 2026, although its commercial paper program permits up to $2.0 billion of short-term notes. Bank guarantees, surety bonds, and similar instruments increased to approximately $93 million from $82 million at year-end 2025.

Key facts

• Commercial paper program allows issuance up to $2.0 billion aggregate principal amount; there was no commercial paper outstanding as of June 30, 2026 or December 31, 2025. source
• Total assets as of June 30, 2026: $14,243 million, compared to $14,294 million at December 31, 2025. source
• As of June 30, 2026, Solventum had $403 million of cash and cash equivalents, of which approximately $291 million was held by the Company’s foreign subsidiaries and approximately $112 million was held in the United States. source
• As of December 31, 2025, Solventum had $878 million of cash and cash equivalents, of which approximately $800 million was held by the Company’s foreign subsidiaries and $78 million was held in the United States. source
• As of June 30, 2026, total current assets: $3,741 million, down from $3,859 million at December 31, 2025. source
• Basic earnings per share were $0.53 and $0.52 for the three months ended June 30 (two columns) and $0.60 and $1.31 for the six months ended June 30 (two columns). source
• Diluted earnings per share were $0.53 and $0.51 for the three months ended June 30 (two columns) and $0.60 and $1.30 for the six months ended June 30 (two columns). source
• Contractual capital commitments represent a small part of the Company’s expected capital spending. source

Impact estimates